KBC Group NV lifted its holdings in Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) by 31.8% in the 3rd quarter, Holdings Channel reports. The firm owned 2,385 shares of the company’s stock after acquiring an additional 576 shares during the period. KBC Group NV’s holdings in Surgery Partners were worth $77,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. DekaBank Deutsche Girozentrale increased its holdings in Surgery Partners by 102.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock worth $80,000 after buying an additional 1,375 shares in the last quarter. Quarry LP boosted its holdings in shares of Surgery Partners by 133.1% during the 2nd quarter. Quarry LP now owns 3,082 shares of the company’s stock valued at $73,000 after acquiring an additional 1,760 shares during the last quarter. Creative Planning bought a new stake in shares of Surgery Partners in the third quarter worth approximately $258,000. Versor Investments LP bought a new position in Surgery Partners during the third quarter valued at approximately $271,000. Finally, MeadowBrook Investment Advisors LLC lifted its position in Surgery Partners by 15.9% during the second quarter. MeadowBrook Investment Advisors LLC now owns 12,320 shares of the company’s stock valued at $293,000 after purchasing an additional 1,690 shares during the period.
Surgery Partners Trading Down 1.5 %
Surgery Partners stock opened at $23.01 on Friday. Surgery Partners, Inc. has a 12-month low of $21.36 and a 12-month high of $36.92. The firm has a market capitalization of $2.92 billion, a price-to-earnings ratio of -48.67, a P/E/G ratio of 16.71 and a beta of 2.76. The firm has a 50 day moving average of $30.02 and a 200 day moving average of $28.37. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on SGRY. Royal Bank of Canada decreased their target price on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research note on Wednesday. Cantor Fitzgerald reiterated an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a research report on Friday, October 4th. Benchmark reissued a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a research report on Monday, August 26th. Macquarie reaffirmed an “outperform” rating and set a $34.00 price target on shares of Surgery Partners in a research report on Tuesday. Finally, Citigroup dropped their price objective on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $38.71.
View Our Latest Research Report on Surgery Partners
About Surgery Partners
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Read More
- Five stocks we like better than Surgery Partners
- NYSE Stocks Give Investors a Variety of Quality Options
- Tesla Investors Continue to Profit From the Trump Trade
- Best Stocks Under $10.00
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Compound Interest and Why It Matters When Investing
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRY – Free Report).
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.